NPR logo

High Drug Costs: Industry Perspective

  • Download
  • <iframe src="https://www.npr.org/player/embed/4113399/4113400" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
High Drug Costs: Industry Perspective

Health Care

High Drug Costs: Industry Perspective

High Drug Costs: Industry Perspective

  • Download
  • <iframe src="https://www.npr.org/player/embed/4113399/4113400" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

NPR's Jennifer Ludden talks with Dr. Paul Antony, chief medical officer for the Pharmaceutical Research and Manufacturers of America. He offers the drug industry's perspective on the rising costs of prescription drugs, and responds to charges made Saturday by Dr. Marcia Angell, who accuses pharmaceutical companies of spending too much on advertising and making undue profits.

Related NPR Stories